Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling - Part 3
- PMID: 34455943
- DOI: 10.2174/138920022206210708103019
Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling - Part 3
Similar articles
-
Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling: Part 1.Curr Drug Metab. 2020;21(7):480-481. doi: 10.2174/138920022107200925101631. Curr Drug Metab. 2020. PMID: 33172364 No abstract available.
-
Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases & their Metabolic Profiling-Part 2.Curr Drug Metab. 2020;21(14):1070-1071. doi: 10.2174/138920022114201230142204. Curr Drug Metab. 2020. PMID: 33413055 No abstract available.
-
Editorial (Thematic Issue: Natural Leads in Drug Discovery against Metabolic Disorders and their Related Infectious Diseases).Curr Top Med Chem. 2016;16(23):2523-4. doi: 10.2174/1568026616999160510121418. Curr Top Med Chem. 2016. PMID: 27439612 No abstract available.
-
Metabolomics in infectious diseases and drug discovery.Mol Omics. 2021 Jun 14;17(3):376-393. doi: 10.1039/d1mo00017a. Mol Omics. 2021. PMID: 34125125 Free PMC article. Review.
-
Metabolomic tools used in marine natural product drug discovery.Expert Opin Drug Discov. 2020 Apr;15(4):499-522. doi: 10.1080/17460441.2020.1722636. Epub 2020 Feb 6. Expert Opin Drug Discov. 2020. PMID: 32026730 Review.
Cited by
-
The role of nanomaterials in enhancing natural product translational potential and modulating endoplasmic reticulum stress in the treatment of ovarian cancer.Front Pharmacol. 2022 Oct 26;13:987088. doi: 10.3389/fphar.2022.987088. eCollection 2022. Front Pharmacol. 2022. PMID: 36386196 Free PMC article. Review.
-
Editorial: Exploration of Natural Product Leads for Multitarget-Based Treatment of Cancer-Computational to Experimental Journey.Front Pharmacol. 2022 Feb 22;13:850151. doi: 10.3389/fphar.2022.850151. eCollection 2022. Front Pharmacol. 2022. PMID: 35273512 Free PMC article. No abstract available.
-
Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.Front Pharmacol. 2022 Feb 21;13:801733. doi: 10.3389/fphar.2022.801733. eCollection 2022. Front Pharmacol. 2022. PMID: 35264951 Free PMC article. Review.
-
Translational Informatics for Natural Products as Antidepressant Agents.Front Cell Dev Biol. 2022 Jan 20;9:738838. doi: 10.3389/fcell.2021.738838. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35127696 Free PMC article. Review.
-
Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies.Front Cell Dev Biol. 2021 Nov 5;9:745177. doi: 10.3389/fcell.2021.745177. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805155 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
